Immunomodulatory Arming Factors—The Current Paradigm for Oncolytic Vectors Relies on Immune Stimulating Molecules
The dogma of engineering oncolytic viral vectors has shifted from emphasizing the viral lysis of individual cancer cells to the recruitment and coordination of the adaptive immune system to clear the tumor. To accomplish this, researchers have been adding several classes of transgenes to their prefe...
Main Authors: | Cole W. D. Peters, Fares Nigim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/16/9051 |
Similar Items
-
Arming viruses in multi-mechanistic oncolytic viral therapy: current research and future developments, with emphasis on poxviruses
by: Sampath P, et al.
Published: (2013-12-01) -
Optimizing Oncolytic Viral Design to Enhance Antitumor Efficacy: Progress and Challenges
by: Shyambabu Chaurasiya, et al.
Published: (2020-06-01) -
Monitoring the Efficacy of Oncolytic Viruses via Gene Expression
by: Ashley Ansel, et al.
Published: (2017-11-01) -
Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development
by: Tiffany Y. Ho, et al.
Published: (2021-09-01) -
Oncolytic virus immunotherapy: future prospects for oncology
by: Junaid Raja, et al.
Published: (2018-12-01)